Multivariate genomic analysis of 1.5 million people identifies genes related to addiction, antisocial behavior, and health
Richard Karlsson Linnér,
Travis Triplett Mallard,
Peter B Barr,
James W. Madole,
Morgan N Driver,
Holly E Poore,
Andrew D. Grotzinger,
Jorim J. Tielbeek,
Emma C. Johnson,
Joelle A Pasman,
Karin J. H. Verweij,
Kathleen Mullan Harris,
Elliot M Tucker-Drob,
Irwin D. Waldman,
Abraham A Palmer,
Kathryn Paige Harden,
Philipp D. Koellinger,
Danielle M Dick
Posted 16 Oct 2020
bioRxiv DOI: 10.1101/2020.10.16.342501
Posted 16 Oct 2020
Behaviors and disorders related to self-regulation, such as substance use, antisocial conduct, and ADHD, are collectively referred to as externalizing and have a shared genetic liability. We applied a multivariate approach that leverages genetic correlations among externalizing traits for genome-wide association analyses. By pooling data from ~1.5 million people, our approach is statistically more powerful than single-trait analyses and identifies more than 500 genetic loci. The identified loci were enriched for genes expressed in the brain and related to nervous system development. A polygenic score constructed from our results captures variation in a broad range of behavioral and medical outcomes that were not part of our genome-wide analyses, including traits that until now lacked well-performing polygenic scores, such as opioid use disorder, suicide, HIV infections, criminal convictions, and unemployment. Our findings are consistent with the idea that persistent difficulties in self-regulation can be conceptualized as a neurodevelopmental condition. ### Competing Interest Statement Dr. Kranzler is a member of the American Society of Clinical Psychopharmacology's Alcohol Clinical Trials Initiative, which was supported in the last three years by AbbVie, Alkermes, Ethypharm, Indivior, Lilly, Lundbeck, Otsuka, Pfizer, Arbor, and Amygdala Neurosciences. Drs. Kranzler and Gelernter are named as inventors on PCT patent application #15/878,640 entitled: "Genotype-guided dosing of opioid agonists," filed January 24, 2018. Dr. Gelernter did paid editorial work for the journal Complex Psychiatry. Authors declare no other competing interests.
- Downloaded 2,689 times
- Download rankings, all-time:
- Site-wide: 4,889
- In genetics: 218
- Year to date:
- Site-wide: 2,530
- Since beginning of last month:
- Site-wide: 1,791
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!